UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 327

Sortiert nach

Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity

Cancer research (Chicago, Ill.), 2017-05, Vol.77 (9), p.2292-2305

2017

Link zum Volltext

Verfügbarkeit prüfen

STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice

Cancer Immunology, Immunotherapy, 2015-08, Vol.64 (8), p.1057-1066

2015

Link zum Volltext

Verfügbarkeit prüfen

Toll-like receptor ligands energize peptide vaccines through multiple paths

Cancer research (Chicago, Ill.), 2007-09, Vol.67 (17), p.7945-7947

CELIS, Esteban

2007

Link zum Volltext

Verfügbarkeit prüfen

Poly-ICLC, a multi-functional immune modulator for treating cancer

Seminars in immunology, 2020-06, Vol.49, p.101414-101414, Article 101414

2020

Link zum Volltext

Verfügbarkeit prüfen

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model

Nature communications, 2019-03, Vol.10 (1), p.1430-1430, Article 1430

2019

Link zum Volltext

Verfügbarkeit prüfen

Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer

Nature communications, 2017-12, Vol.8 (1), p.2122-16, Article 2122

2017

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

Cancer Immunology, Immunotherapy, 2017-06, Vol.66 (6), p.705-716

2017

Link zum Volltext

Verfügbarkeit prüfen

A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy

Cancer science, 2021-07, Vol.112 (7), p.2705-2713

2021

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

The Journal of clinical investigation, 2010-04, Vol.120 (4), p.1111-1124

2010

Link zum Volltext

Verfügbarkeit prüfen

Oxidized lipids block antigen cross-presentation by dendritic cells in cancer

The Journal of immunology (1950), 2014-03, Vol.192 (6), p.2920-2931

2014

Link zum Volltext

Verfügbarkeit prüfen

A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment

Cancer Immunology, Immunotherapy, 2021-08, Vol.70 (8), p.2301-2312

2021

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by Ex Vivo PI3K-δ Inhibition

Cancer research (Chicago, Ill.), 2017-08, Vol.77 (15), p.4135-4145

2017

Link zum Volltext

Verfügbarkeit prüfen

The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice

Cancer Immunology, Immunotherapy, 2019-03, Vol.68 (3), p.455-466

2019

Link zum Volltext

Verfügbarkeit prüfen

Autophagy Induced by Conventional Chemotherapy Mediates Tumor Cell Sensitivity to Immunotherapy

Cancer research (Chicago, Ill.), 2012-11, Vol.72 (21), p.5483-5493

2012

Link zum Volltext

Verfügbarkeit prüfen

Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery

Cancer Immunology, Immunotherapy, 2021-12, Vol.70 (12), p.3421-3434

2021

Link zum Volltext

Verfügbarkeit prüfen

Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms

The Journal of immunology (1950), 2013-02, Vol.190 (4), p.1873-1881

2013

Link zum Volltext

Verfügbarkeit prüfen

Multiple roles for CD4⁺ T cells in anti-tumor immune responses

Immunological reviews, 2008-04, Vol.222 (1), p.129-144

2008

Link zum Volltext

Verfügbarkeit prüfen

Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration

Journal for immunotherapy of cancer, 2020-09, Vol.8 (2), p.e001224

2020

Link zum Volltext

Verfügbarkeit prüfen

Designing therapeutic cancer vaccines by mimicking viral infections

Cancer Immunology, Immunotherapy, 2017-02, Vol.66 (2), p.203-213

2017

Link zum Volltext

Verfügbarkeit prüfen

CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma

Cancer Immunology, Immunotherapy, 2015-06, Vol.64 (6), p.697-705

2015

Link zum Volltext

Verfügbarkeit prüfen

Immune-mediated Tumor Regression Induced by CpG-containing Oligodeoxynucleotides

Clinical cancer research, 2003-07, Vol.9 (7), p.2693-2700

2003

Link zum Volltext

Verfügbarkeit prüfen

PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma

Journal of translational medicine, 2019-06, Vol.17 (1), p.207-207, Article 207

2019

Link zum Volltext

Verfügbarkeit prüfen

Vaccine-Elicited CD8+ T Cells Protect against Respiratory Syncytial Virus Strain A2-Line19F-Induced Pathogenesis in BALB/c Mice

Journal of Virology, 2012-12, Vol.86 (23), p.13016-13024

2012

Link zum Volltext

Verfügbarkeit prüfen

Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma

Oncoimmunology, 2021-01, Vol.10 (1), p.1856545-1856545

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma

Scientific reports, 2015-11, Vol.5 (1), p.16280-16280, Article 16280

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 327

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(303)
Mit Volltextzugriff
(302)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(203)
Life Sciences & Biomedicine
(192)
Humans
(144)
Animals
(114)
Immunology
(95)
Mice
(90)
Oncology
(88)
Biological And Medical Sciences
(82)
Female
(68)
Immunotherapy
(64)
Medical Sciences
(64)
T-Lymphocytes, Cytotoxic - Immunology
(62)
Tumors
(62)
Mice, Inbred C57bl
(45)
Epitopes, T-Lymphocyte - Immunology
(43)
Male
(42)
Pharmacology. Drug Treatments
(39)
Antineoplastic Agents
(37)
Amino Acid Sequence
(35)
Antigens
(33)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity

STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice

Toll-like receptor ligands energize peptide vaccines through multiple paths

Poly-ICLC, a multi-functional immune modulator for treating cancer

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model

Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

Oxidized lipids block antigen cross-presentation by dendritic cells in cancer

A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment

Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by Ex Vivo PI3K-δ Inhibition

The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice

Autophagy Induced by Conventional Chemotherapy Mediates Tumor Cell Sensitivity to Immunotherapy

Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery

Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms

Multiple roles for CD4⁺ T cells in anti-tumor immune responses

Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration

Designing therapeutic cancer vaccines by mimicking viral infections

CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma

Immune-mediated Tumor Regression Induced by CpG-containing Oligodeoxynucleotides

PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma

Vaccine-Elicited CD8+ T Cells Protect against Respiratory Syncytial Virus Strain A2-Line19F-Induced Pathogenesis in BALB/c Mice

Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma

Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma

Suchergebnisse filtern